AAAAAA
Results:
1-19
|
Results: 19
Authors:
De Lena, M
Lorusso, V
Latorre, A
Fanizza, G
Gargano, G
Caporusso, L
Guida, M
Catino, A
Crucitta, E
Sambiasi, D
Mazzei, A
Citation: M. De Lena et al., Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study, EUR J CANC, 37(3), 2001, pp. 364-368
Authors:
Paradiso, A
Schittulli, F
Cellamare, G
Mangia, A
Marzullo, F
Lorusso, V
De Lena, M
Citation: A. Paradiso et al., Randomized clinical trial of adjuvant fluorouracil, epirubicin, and cyclophosphamide chemotherapy for patients with fast-proliferating, node-negativebreast cancer, J CL ONCOL, 19(19), 2001, pp. 3929-3937
Authors:
Paradiso, A
Simone, G
De Lena, M
Leone, B
Vallejo, C
Lacava, J
Dellapasqua, S
Daidone, MG
Costa, A
Citation: A. Paradiso et al., Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer, BR J CANC, 84(5), 2001, pp. 651-658
Authors:
De Lena, M
Latorre, A
Calabrese, P
Catino, A
Lorusso, V
Mazzei, A
Aloe, A
Citation: M. De Lena et al., High efficacy of paclitaxel and doxorubicin as first-line therapy in advanced breast cancer: A phase I-II study, J CHEMOTHER, 12(4), 2000, pp. 367-373
Authors:
Crucitta, E
Lorusso, V
Attolico, M
Sambiasi, D
Mazzei, A
De Lena, M
Citation: E. Crucitta et al., New aromatase inhibitors in the treatment of advanced breast cancer (review), INT J ONCOL, 17(5), 2000, pp. 1037-1041
Authors:
Lorusso, V
Palmieri, G
Bianco, AR
Abate, G
Catalano, G
De Vita, F
Dammacco, F
Lauta, VM
Lucarelli, G
Polimeno, G
Mantovani, G
D'Aprile, M
Marzullo, F
De Lena, M
Citation: V. Lorusso et al., CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group, INT J ONCOL, 16(1), 2000, pp. 149-154
Authors:
Comella, P
De Vita, F
Mancarella, S
De Lucia, L
Biglietto, M
Casaretti, R
Farris, A
Ianniello, GP
Lorusso, V
Avallone, A
Carteni, G
Leo, S
Catalano, G
De Lena, M
Comella, G
Citation: P. Comella et al., Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: A Southern Italy Cooperative Oncology Group phase II-III randomized trial, ANN ONCOL, 11(10), 2000, pp. 1323-1333
Authors:
Lorusso, V
Carpagnano, F
Frasci, G
Panza, N
Di Rienzo, G
Cisternino, ML
Napoli, G
Orlando, S
Cinieri, S
Brunetti, C
Palazzo, S
De Lena, M
Citation: V. Lorusso et al., Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer, J CL ONCOL, 18(2), 2000, pp. 405-411
Authors:
Berruti, A
Sperone, P
Bottini, A
Gorzegno, G
Lorusso, V
Brunelli, A
Botta, M
Tampellini, M
Donadio, M
Mancarella, S
De Lena, M
Alquati, P
Dogliotti, L
Citation: A. Berruti et al., Phase II study of vinorelbine with protracted fluorouracil infusion as a second- or third-line approach for advanced breast cancer patients previously treated with anthracyclines, J CL ONCOL, 18(19), 2000, pp. 3370-3377
Authors:
Frasci, G
Lorusso, V
Panza, N
Comella, P
Nicolella, G
Bianco, A
De Cataldis, G
Iannelli, A
Bilancia, D
Belli, M
Massidda, B
Piantedosi, F
Comella, G
De Lena, M
Citation: G. Frasci et al., Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer, J CL ONCOL, 18(13), 2000, pp. 2529-2536
Authors:
Lorusso, V
Manzione, L
De Vita, F
Antimi, M
Selvaggi, FP
De Lena, M
Citation: V. Lorusso et al., Gemcitabine plus cisplatin for advanced transitional cell carcinoma of theurinary tract: A phase II multicenter trial, J UROL, 164(1), 2000, pp. 53-56
Authors:
Paradiso, A
Simone, G
Petroni, S
Leone, B
Vallejo, C
Lacava, J
Romero, A
Machiavelli, M
De Lena, M
Allegra, CJ
Johnston, PG
Citation: A. Paradiso et al., Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients, BR J CANC, 82(3), 2000, pp. 560-567
Authors:
Gargano, G
Fanizza, G
Polignano, G
Lorusso, V
De Lena, M
Citation: G. Gargano et al., A new protocol of iron therapy combined with epoetin alpha as a treatment for preoperative autologous blood donation in gynaecological tumor surgery, ONCOL REP, 6(6), 1999, pp. 1349-1352
Authors:
Gargano, G
Polignano, G
De Lena, M
Brandi, M
Lorusso, V
Fanizza, G
Citation: G. Gargano et al., The utility of a growth factor: r-HuEPO as a treatment for preoperative autologous blood donation in gynecological tumor surgery, INT J ONCOL, 14(1), 1999, pp. 157-160
Authors:
Frasci, G
Panza, N
Cornella, P
Nicolella, GP
Natale, M
Manzione, L
Bilancia, D
Cioffi, R
Maiorino, L
De Cataldis, G
Belli, M
Micillo, E
Mascia, V
Massidda, B
Lorusso, V
De Lena, M
Carpagnano, F
Contu, A
Pusceddu, G
Comella, G
Citation: G. Frasci et al., Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: A phase I-II study, J CL ONCOL, 17(8), 1999, pp. 2316-2325
Authors:
Comella, P
Frasci, G
Panza, N
Manzione, L
Lorusso, V
Di Rienzo, G
Cioffi, R
De Cataldis, G
Maiorino, L
Bilancia, D
Nicolella, G
Natale, M
Carpagnano, F
Pacilio, C
De Lena, M
Bianco, A
Comella, G
Citation: P. Comella et al., Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: A phase II randomized study of the Southern ItalyCooperative Oncology Group, J CL ONCOL, 17(5), 1999, pp. 1526-1534
Authors:
Comella, P
Lorusso, V
Casaretti, R
De Lucia, L
Carteni, G
Manzione, L
Mancarella, S
De Lena, M
Comella, G
Citation: P. Comella et al., Concurrent modulation of 5-fluorouracil with methotrexate and L-leucovorin: An effective and moderately toxic regimen for the treatment of advanced colorectal carcinoma - A multicenter phase II study of the Southern Italy Cooperative Oncology Group, TUMORI, 85(6), 1999, pp. 465-472
Authors:
Lorusso, V
Mancarella, S
Catino, A
Brandi, M
Paradiso, A
Latorre, A
Mastria, A
De Mitrio, A
De Lena, M
Citation: V. Lorusso et al., Mitoxantrone, l-leucovorin and 5-fluorouracil: An effective and well tolerated first-line treatment for advanced breast cancer, TUMORI, 85(1), 1999, pp. 60-64
Authors:
Paradiso, A
Tommasi, S
Barletta, A
Leone, B
Lacava, J
Vellejo, C
Labriola, A
Marzullo, F
Altieri, R
Schittulli, F
De Lena, M
Citation: A. Paradiso et al., Metastatic site and p53 primary tumor expression in previously untreated stage IV breast cancer patients, ANTICANC R, 19(5C), 1999, pp. 4523-4528
Risultati:
1-19
|